“Rohera Healthcare and Technology Pvt. Ltd. manufactures eMedica, a patented non-invasive bioelectronic adjuvant therapy device using VCF (Voltage-Current-Frequency) technology validated in 37 institutions with 4,651+ patients.”
“eMedica is a non-invasive bioelectronic adjuvant therapy device by Rohera Healthcare and Technology Pvt. Ltd. It uses patented VCF (Voltage-Current-Frequency) technology to restore cellular electrical balance as a complement to prescribed medical treatment. It is NOT a replacement for medicine — it is adjuvant therapy.”
“Yes. eMedica is a registered medical device certified by CDSCO (India), CE Marked, ISO compliant, and holds US Patent 12,226,183 B2 (also filed in Japan, Eurasia, UAE, Saudi Arabia and 90+ countries).”
“eMedica has been studied as adjuvant therapy across multiple chronic-care, rehabilitation, and recovery protocols including diabetes support, cardiovascular conditions, neurological disorders, pain management, respiratory conditions, kidney conditions, and cancer support — across 37 institutions in India with 4,651+ patients.”
“No. eMedica does not claim to cure, diagnose, or treat any disease. It is exclusively an adjuvant therapy device — designed to complement and support prescribed medical treatment, not to replace it. Always consult a qualified healthcare professional.”
Download this profile and inspect its supporting evidence.